News
Prescription savings platform GoodRx is collaborating with pharma giant Novo Nordisk to make Ozempic and Wegovy pens ...
FDA cites Indiana drug plant for contamination, pest issues, and unresolved equipment failures, raising concerns over pharma manufacturing quality.
An FDA Form 483 cited unaddressed contamination, pest infestations, and equipment failures at manufacturer’s Bloomington, IN ...
Drugmaker Novo Nordisk received accelerated approval for the drug’s use in people with moderate to advanced liver scarring, ...
Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.
A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side ...
7h
Investor's Business Daily on MSNArgenx Tops Buy Point On Bullish Study, 850 Price Target
The news came as RBC Capital analyst Luca Issi initiated coverage on Argenx with an outperform rating and 850 price target, saying that doctor checks point to accelerating uptake of Vyvgart, according ...
Hims & Hers Health is facing a securities class action lawsuit following the past termination of its partnership with Novo Nordisk, amid allegations related to the promotion of unauthorized versions ...
The Food and Drug Administration (FDA) has raised alarms over counterfeit versions of the diabetes medication Ozempic infiltrating the U.S. supply chain. This critical warning comes as the FDA seized ...
The US Food and Drug Administration (FDA) granted approval for a second treatment for metabolic dysfunction-associated ...
The FDA has granted accelerated approval of Wegovy® (semaglutide) for adults with moderate to advanced metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results